Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3063)
All Articles published online
|
Dec 7, 2010 (publication date) through Dec 12, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mummadi RR, Petersen JR, Xiao SY, Snyder N. Role of simple biomarkers in predicting fibrosis progression in HCV infection. World J Gastroenterol 2010; 16(45): 5710-5715 [PMID: 21128320 DOI: 10.3748/wjg.v16.i45.5710] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i45/5710.htm |
| Number | Citing Articles |
| 1 |
Carolina Rumbo, María Inés Martinez, Ana Cabanne, Julio Trentadue, Adriana Fernández, Gabriel Gondolesi. Utility of Aminotransferase/Platelet Ratio Index to Predict Liver Fibrosis in Intestinal Failure–Associated Liver Disease in Pediatric Patients. Journal of Parenteral and Enteral Nutrition 2017; 41(5): 884 doi: 10.1177/0148607115625779
|
| 2 |
N. Tamaki, M. Kurosaki, K. Tanaka, Y. Suzuki, Y. Hoshioka, T. Kato, Y. Yasui, T. Hosokawa, K. Ueda, K. Tsuchiya, H. Nakanishi, J. Itakura, Y. Asahina, N. Izumi. Noninvasive estimation of fibrosis progression overtime using the FIB‐4 index in chronic hepatitis C. Journal of Viral Hepatitis 2013; 20(1): 72 doi: 10.1111/j.1365-2893.2012.01635.x
|
| 3 |
Agnieszka Bakula, Maciej Dadalski. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_2-1
|
| 4 |
Sohan Lal Solanki, Jasmeen Kaur, Amit M. Gupta, Shraddha Patkar, Riddhi Joshi, Reshma P. Ambulkar, Akshay Patil, Mahesh Goel. Cancer related nutritional and inflammatory markers as predictive parameters of immediate postoperative complications and long-term survival after hepatectomies. Surgical Oncology 2021; 37: 101526 doi: 10.1016/j.suronc.2021.101526
|
| 5 |
Monica A. Konerman, Yiwei Zhang, Ji Zhu, Peter D.R. Higgins, Anna S.F. Lok, Akbar K. Waljee. Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal data. Hepatology 2015; 61(6): 1832 doi: 10.1002/hep.27750
|
| 6 |
Chia-Chi Wang, Chen-Hua Liu, Chih-Lin Lin, Pin-Chao Wang, Tai-Chung Tseng, Hans Hsienhong Lin, Jia-Horng Kao. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients. Journal of the Formosan Medical Association 2015; 114(10): 923 doi: 10.1016/j.jfma.2015.07.004
|
| 7 |
M. A. Konerman, S. Yapali, A. S. Lok. Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring – predictors and predictive models of disease progression. Alimentary Pharmacology & Therapeutics 2014; 40(8): 863 doi: 10.1111/apt.12921
|
| 8 |
Jacinta A. Holmes, Alexander J. Thompson, Leon A. Adams. Biomarkers of Fibrosis and Fibrosis Progression in Chronic Hepatitis C. Current Hepatitis Reports 2012; 11(4): 231 doi: 10.1007/s11901-012-0148-0
|
| 9 |
S. D. Holmberg, M. Lu, L. B. Rupp, L. E. Lamerato, A. C. Moorman, V. Vijayadeva, J. A. Boscarino, E. M. Henkle, S. C. Gordon, S. D. Holmberg, E. H. Teshale, P. R. Spradling, A. C. Moorman, S. C. Gordon, D. R. Nerenz, M. Lu, L. Lamerato, L. B. Rupp, N. Akkerman, N. J. Oja-Tebbe, C. M. Cogan, D. Larkin, J. A. Boscarino, Z. S. Daar, R. E. Smith, P. J. Curry, B. D. Geise, J. B. Leader, C. C. Nakasato, V. Vijayadeva, K. E. Sylva, J. V. Parker, M. M. Schmidt, E. M. Henkle, T. L. Dodge, E. M. Keast, L. Drew. Noninvasive Serum Fibrosis Markers for Screening and Staging Chronic Hepatitis C Virus Patients in a Large US Cohort. Clinical Infectious Diseases 2013; 57(2): 240 doi: 10.1093/cid/cit245
|
| 10 |
Peter Ferenci, Rodrigo Aires, Kimberly L. Beavers, Manuela Curescu, Paulo R. Abrão Ferreira, Michael Gschwantler, Stefan Ion, Dominique Larrey, Mojca Maticic, Massimo Puoti, János Schuller, Istvan Tornai, Anna Tusnádi, Diethelm Messinger, Fernando Tatsch, Andrzej Horban. Predictive value of FIB-4 and APRI versus METAVIR on sustained virologic response in genotype 1 hepatitis C patients. Hepatology International 2014; 8(1): 83 doi: 10.1007/s12072-013-9484-6
|
| 11 |
Yuemin Nan, Xuemin Niu, Rongqi Wang, Suxian Zhao, Na Fu, Jinghua Du, Yang Wang, Baoyu Wang, Yuguo Zhang. microRNA‑1273g‑3p is a useful non‑invasive test for the prediction of liver fibrosis in patients with chronic hepatitis C. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.7114
|
| 12 |
Xing-Xi Gao, Da-Hua Shi, Yun-Xi Chen, Jiang-Tao Cui, Yu-Rong Wang, Chun-Ping Jiang, Jun-Hua Wu. The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation. Archives of Pharmacal Research 2012; 35(8): 1479 doi: 10.1007/s12272-012-0819-y
|
| 13 |
Kian Bichoupan, Valerie Martel-Laferriere, David Sachs, Michel Ng, Emily A. Schonfeld, Alexis Pappas, James Crismale, Alicia Stivala, Viktoriya Khaitova, Donald Gardenier, Michael Linderman, Ponni V. Perumalswami, Thomas D. Schiano, Joseph A. Odin, Lawrence Liu, Alan J. Moskowitz, Douglas T. Dieterich, Andrea D. Branch. Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology 2014; 60(4): 1187 doi: 10.1002/hep.27340
|
| 14 |
Janine Rohrbach, Felix Stickel, Patrick Schmid, Wolfgang Thormann, Helen Kovari, Alexandra Scherrer, Huldrych F Günthard, Danielle Vuichard, Matthias Cavassini, Juan Ambrosioni, Enos Bernasconi, Hansjakob Furrer, Andri Rauch. Changes in Biomarkers of Liver Disease during Successful Combination Antiretroviral Therapy in HIV–HCV-Coinfected Individuals. Antiviral Therapy 2014; 19(2): 149 doi: 10.3851/IMP2686
|
| 15 |
Abdel-Rahman Zekri, Mohamed El-Kassas, Yasmin Saad, Abeer Bahnassy, Hany Khatab Sameh Seif El-Din, Samar K. Darweesh, Hanan Abdel Hafez, Gamal Esmat. Caspase recruitment domains. New potential markers for diagnosis of hepatocellular carcinoma associated with HCV in Egyptian patients. Annals of Hepatology 2013; 12(5): 774 doi: 10.1016/S1665-2681(19)31319-5
|
| 16 |
Agnieszka Bakula, Maciej Dadalski. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 305 doi: 10.1007/978-94-007-7675-3_2
|
| 17 |
Konstantinos C. Fragkos, María Claudia Picasso Bouroncle, Shankar Kumar, Lucy Caselton, Alex Menys, Alan Bainbridge, Stuart A. Taylor, Francisco Torrealdea, Tomoko Kumagai, Simona Di Caro, Farooq Rahman, Jane Macnaughtan, Manil D. Chouhan, Shameer Mehta. Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility Study. Nutrients 2020; 12(7): 2151 doi: 10.3390/nu12072151
|